knowledge -WSS

knowledge

author：knowledge 2025-09-04 05:34:35 - browse：572

Five people put coins in a box containing coins and cash on stage — coverage from STAT — Adobe

In the United States, health care costs are so out of control that medical crowdfunding has become commonplace. The idea is simple: turn your social network into a financial safety net to cover the cost of expensive treatments or long illnesses. Millions of Americans have started crowdfunding campaigns for medical bills, and tens of millions have donated to them, mostly through the undisputed sector leader, GoFundMe.

Nora Kenworthy, a nursing and health studies professor at the University of Washington, Bothell, has spent years studying the world of crowdfunding for health care — along with the way it ends up amplifying the inequities that already dictate who goes into medical debt.

In her new book, “Crowded Out: The True Costs of Crowdfunding Healthcare,” which will be released on Tuesday, she looks at what she calls the “toxicities” that drive medical crowdfunding campaigns. STAT spoke with Kenworthy about those issues, as well as the difficult moral decisions potential donors face when deciding whether to contribute. The following interview is condensed and edited for clarity.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Setback for rare diseases as Taysha Gene Therapies pulls back

WSS

CRISPR base editing slashes cholesterol levels in monkeys

Phenylephrine and the overlooked value of the placebo effect

When women are denied an abortion, their children fare worse than peers

Liquid biopsy for lung cancer is launched by Delfi

FDA panel signals lack of confidence in Amgen cancer drug data

When women are denied an abortion, their children fare worse than peers

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

What does generative AI mean for health care? We asked experts

Histogen: Failed biotech offers rare public look inside

Heart attack and stroke risk calculators need revising

Physician executives need more than on

Psychedelics group wrestles with new pharma identity

Lawsuit highlights wrinkle for disputes over surprise medical bills

Walensky prepares to leave CDC — and Congress — behind

6 solutions to address cancer drug shortages and others

Heart attack and stroke risk calculators need revising

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

focus

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Analysis of telehealth claims data suggest service duplication

Colorectal cancer study finds potential in overlooked immune cell

European officials brace for rough respiratory virus season

CDC picks Alphabet's Verily for wasterwater surveillance contract

Chemotherapy drug shortage eases slightly but still widespread

Wikipedia

focus

hotspot

entertainment